Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 538.00
Bid: 540.00
Ask: 543.00
Change: 2.00 (0.37%)
Spread: 3.00 (0.556%)
Open: 533.00
High: 549.00
Low: 532.00
Prev. Close: 536.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

30 Sep 2013 17:36

RNS Number : 3316P
Polar Capital Holdings PLC
30 September 2013
 



Polar Capital Holdings plc

30 September 2013

Crystallisation of Business Unit and issue of shares

 

Polar Capital Holdings plc ("Polar Capital" or the "Company") announces the crystallisation of the Preference Shares held by Rob Gurner, head of the Polar Capital European Team and manager of the Polar Capital European Forager and European Conviction Funds, in respect of the Conviction Fund (part of the European business unit) and resultant issue of 1,390,296 new ordinary shares in aggregate which will occur over the next three years to Mr Gurner and members of his team. This crystallisation is expected to be immediately earnings enhancing for shareholders.

 

Mr Gurner crystallised his preference shares in respect of the Forager Fund in 2011 and has one further tranche of 2,468,961 shares under that crystallisation to receive in March 2014.

 

Background

As set out at the time of the Company's admission to AIM, Polar Capital has structured its fund management operations in such a way that the fund management teams are placed in separate business units. Each business unit is a separate profit centre and the fund managers responsible receive each year a payment which comprises a share of their unit's core operating profit (operating profit before performance fees and related distributions) and performance fees.

 

In addition to the remuneration structure described above, each fund management team is offered the prospect of an interest in the capital of the Company through the purchase of an individual class of preference shares in Polar Capital Partners Limited, a wholly owned subsidiary of the Company. These preference shares have been structured in such a way as to become convertible upon the occurrence of certain events known as crystallisation events into cash or, at the option of the Company, ordinary shares at a ratio that is intended to be earnings enhancing for the Group.

 

Upon the occurrence of a crystallisation event the fund managers concerned cease to be eligible to receive their legacy share of the business unit's core operating profit and simultaneously going forward receive a reduced interest in their performance fees.

 

European business unit crystallisation

With effect from 31 March 2013 the European business unit elected to crystallise their preference shares in relation to the Conviction Fund and the Company has elected to satisfy the consideration by the issue of new ordinary shares.

 

The Company will issue a total of 1,390,296 new ordinary shares spread over the next three years, which will rank pari passu with the Company's existing ordinary shares at the time of issue, as follows:

30 September 2013 - 139,030 ordinary shares (the "New Shares")

31 March 2014 - 417,089 ordinary shares

31 March 2015 - 417,089 ordinary shares

31 March 2016 - 407 088 ordinary shares

 

Application has been made to AIM for the New Shares to be admitted to trading and dealings are expected to commence on 4 October 2013.

 

The Company's current issued share capital is 83,063,848 ordinary shares and following admission of the New Shares the total shares in issue will be 83,202,878.

For further information please contact:

Polar Capital +44 (0)20 7227 2700

Tim Woolley (CEO)

John Mansell (CFO)

 

 

Canaccord Genuity +44 (0)20 7523 8000

Simon Bridges

Cameron Duncan

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOELLFVRAEIIVIV
Date   Source Headline
26th Nov 20187:00 amRNSUnaudited Interim Results
22nd Nov 20185:00 pmRNSDirectorate Change
5th Nov 20187:01 amRNSNotice of Results
5th Nov 20187:00 amRNSChange of Nominated Adviser and Broker
1st Nov 20187:00 amRNSTotal Voting Rights
25th Oct 20185:26 pmRNSIssue of Equity
24th Oct 20184:52 pmRNSDirector/PDMR Shareholding
17th Oct 20185:49 pmRNSIssue of Equity
15th Oct 201812:38 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
12th Oct 20182:52 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
11th Oct 20184:42 pmRNSIssue of Equity
11th Oct 20187:01 amRNSCrystallisation of business unit & issue of shares
11th Oct 20187:00 amRNSAUM Update
3rd Oct 201810:24 amRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
19th Sep 201811:52 amRNSForm 8.3 - Jardine Lloyd Thompson Group
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
17th Aug 20189:27 amRNSDirectorate Change
6th Aug 20187:00 amRNSBlock listing Interim Review
1st Aug 20187:00 amRNSTotal Voting Rights
31st Jul 20185:57 pmRNSIssue of Equity
31st Jul 201811:29 amRNSDirector/PDMR Shareholding
25th Jul 20183:38 pmRNSDirectorate Change
25th Jul 20183:26 pmRNSResult of AGM
19th Jul 201811:13 amRNSForm 8.3 - Consort Medical Plc
18th Jul 20184:21 pmRNSDirector/PDMR Shareholding
18th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
17th Jul 201810:58 amRNSForm 8.3 - Consort Medical Plc
16th Jul 20183:44 pmRNSDirector/PDMR Shareholding
12th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
12th Jul 20187:00 amRNSAuM Update
11th Jul 201811:06 amRNSForm 8.3 - Consort Medical Plc
3rd Jul 20186:27 pmRNSHolding(s) in Company
3rd Jul 20186:20 pmRNSIssue of Equity
3rd Jul 201812:07 pmRNSForm 8.3 - Consort Medical Plc
2nd Jul 201810:23 amRNSTotal Voting Rights
29th Jun 20187:00 amRNSBlock Listing Application
28th Jun 20185:55 pmRNSAnnual Financial Report
25th Jun 20187:00 amRNSGroup Audited Results for year ended 31 March 2018
11th Jun 201811:27 amRNSNet Asset Value(s)
1st Jun 20187:41 amRNSTotal Voting Rights
24th May 201810:59 amRNSDirector/PDMR Shareholding
24th May 20189:35 amRNSIssue of Equity
23rd May 201811:00 amRNSNotice of Results
23rd May 20189:37 amRNSIssue of Equity
18th May 20181:02 pmRNSIssue of Equity
16th May 20185:49 pmRNSIssue of Equity
11th May 20187:00 amRNSIssue of Equity
10th May 20189:56 amRNSDirector/PDMR Shareholding
1st May 20183:52 pmRNSIssue of Equity
12th Apr 20187:00 amRNSAuM Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.